91福利

The Australian Synchrotron invites proposals for beamtime. This enables researchers to benefit from the Australian Synchrotron’s current beamline capabilities. These include:

•imaging and medical;

•infrared microscope;

•THz/Far-IR;

•macromolecular crystallography;

•powder diffraction;

•soft X-ray spectroscopy;

•small and wide angle X-ray scattering;

•X-ray absorption spectroscopy;

•X-ray fluorescence microscopy.

The service is available for all researchers who are publishing results in open literature. All users must have an approved experiment authorisation and a valid facility safety training.

The Innovations Partnership Schemes (IPS) are designed to transfer technology and expertise developed through STFC funding to the marketplace in partnership with industry and other academic disciplines. STFC technology or expertise must be integral to the project. The technology or expertise can be developed with STFC funding at UK higher education institutes, STFC laboratories, CERN, ESRF and ESO (European Southern Observatory).

A Standard IPS project provides a maximum project value of £150k per annum, over a period not exceeding three years.

Mini IPS provides the facility to make an application for a small project, up to £150k over a period not exceeding 12 months. Mini IPS applications are reviewed alongside the Standard IPS scheme using the same timelines. It will have a lighter touch assessment than for the Standard IPS.

IPS closing dates are every four months.

Applicants are strongly advised to read the Guidance Notes and are encouraged to contact the office to discuss proposals.

The STFC Industrial CASE (Cooperative Awards in Science & Technology) studentship competition provides support for PhD students to work in collaboration with a non-academic partner on projects that fall within the STFC core science programme in astronomy, particle physics and nuclear physics; or that aim to apply technologies or techniques developed within the programme into other areas. Projects involve joint supervision of the student by a member of staff at an academic Research Organisation or related institution and an employee of a non-academic organisation, such as a UK industrial firm, public sector organisation or charity (the non-academic partner).

Industrial CASE awards are for a minimum of 3.5 years. During the period of the award, the student is required to spend a period on the premises of the co-operating body. For a 3.5 year award, the cumulative period should be no less than 9 months but this could be spread over the period of the studentship and would not normally exceed 18 months. Industrial CASE students will receive an enhanced stipend detailed below.

Non-academic partners are required to take part in recruitment and monitoring of the student and to maintain active contact with the student and academic supervisor throughout the period of the studentship. Research Organisations are encouraged to include an industrial external examiner for the PhD.

These extend the standard CASE scheme to help research students become more effective in promoting technology transfer, should their chosen career path take them into either academic research or industry.

For the first three and a half years of the award, CASE-Plus operates in the same way as the CASE scheme; however, CASE-Plus studentships enable students to spend a fourth year working full-time on the premises of the non-academic partner as an employee. During this additional year, the student is employed by the non-academic partner at a salary equivalent to that of a new STFC postdoctoral researcher.

Follow-on Funding is intended to provide financial support at the very early or pre-seed stage of turning research outputs into a commercial proposition. Industry partners are not allowed. If you have an industry partner, please use the IPS scheme.

Follow-On Funding will support a range of relevant activities to enable the development and examination of a concept to establish its commercial feasibility and scientific and technical merit. Partners are not allowed on the Follow-on Fund.

The funding can be used for:

• Undertaking further scientific and technical development of an idea.

• Improving an intellectual property (IP) position.

• Gaining further information about the market for the new products or process.

• Identifying potential licensees or opportunities for joint ventures.

These activities will be prior to:

• A full laboratory demonstration of the idea.

• Pre-production and prototype.

• The availability of commercial funds for development.

Follow-On Funding will specifically not support:

• ‘Blue sky’ research.

• Applied research for companies.

• Associated intellectual property costs e.g. patent costs.

• The purchase of larger equipment and capital.

Innovate UK, the Medical Research Council and Scottish Enterprise invite proposals for their biomedical catalyst business-led early stage awards. These enable businesses to develop innovative healthcare technologies and processes in order to address the growing burden of disease. Proposals should seek to test a well-developed concept and show its effectiveness in a relevant environment, which must be done through:

•experimental evaluation – lab scale;

•initial demonstration using in vitro and in vivo models, however not in human trials;

•exploration of potential production mechanisms;

•early-stage prototyping;

•product development planning;

•intellectual property protection.

Solutions should seek to provide disease prevention and proactive management of health and chronic conditions; earlier and better detection and diagnosis of diseases leading to better patient outcomes; and tailored treatments that either change the underlying disease or offer potential cures.

The Innovations Partnership Schemes (IPS) are designed to transfer technology and expertise developed through STFC funding to the marketplace in partnership with industry and other academic disciplines. STFC technology or expertise must be integral to the project. The technology or expertise can be developed with STFC funding at UK higher education institutes, STFC laboratories, CERN, ESRF and ESO (European Southern Observatory).

A Standard IPS project provides a maximum project value of £150k per annum, over a period not exceeding three years.

Mini IPS provides the facility to make an application for a small project, up to £150k over a period not exceeding 12 months. Mini IPS applications are reviewed alongside the Standard IPS scheme using the same timelines. It will have a lighter touch assessment than for the Standard IPS.

IPS closing dates are every four months.

Innovate UK, the Medical Research Council and Scottish Enterprise invite proposals for their biomedical catalyst business-led feasibility studies. Funding enables businesses to develop solutions to healthcare challenges through the exploration and evaluation of the commercial potential of an early-stage scientific idea. Proposals must address the following challenges:

•reviewing research evidence and identifying applications;

•assessing business opportunities;

•investigating intellectual property issues;

•validating initial concepts or existing pre-clinical work through experimental studies;

•identifying areas for further development.

Solutions should seek to provide disease prevention and proactive management of health and chronic conditions; earlier and better detection and diagnosis of diseases leading to better patient outcomes; and tailored treatments that either change the underlying disease or offer potential cures.